In 2021, the market for negative pressure wound therapy was valued at $2.37 billion. By 2030, it is projected to grow at a strong CAGR of 5.7% to reach $3.92 billion. With a market share of equivalent to USD 702 Mn, North America dominated the sector.
Sub-atmospheric pressures are administered to a wound during a medical technique known as negative wound pressure therapy in order to speed up healing. The therapy is also referred to as vacuum-assisted closure. Through a vacuum device connected to a sponge, a negative level of 125 mmHg beneath ambient pressure is provided to a wound bed. The wound’s surplus fluid is removed by closed suction, which improves circulation, lowers the risk of infection, and removes cellular waste. Injuries that are too big or cannot be treated using standard techniques are managed by NPWT. The clothing can be replaced every 48 to 72 hrs, but it needs to be changed every 12 hours for untreated wounds. The benefits of NPWT include the removal of edema, a reduction in microbial bio-burden, an increase in blood flow, an increase in the creation of granulation tissue, and the provision of a moist environment for wound healing. A recent NPWT application raises the possibility of using it on closed surgical wounds, particularly on closed orthopedic incisional (COI) wounds. A COI wound treated with NPWT heals more quickly and has a lower incidence of postoperative sequelae. t is a common technique for treating a variety of chronic and acute wounds, that are primarily brought on by chronic illnesses.
MARKET INSIGHTS
DRIVERS
- A prominent element driving the growth of the negative pressure therapy market is the rise in chronic wounds experienced by people globally. Approximately 2% of the population in the USA has chronic wounds, according to an NCBI study. Most often, chronic diseases coexist with chronic wounds.
- Along with the population’s rising prevalence of chronic wounds, the development of new and better adverse pressure wound therapy tools and techniques has contributed to the market’s expansion. Negative pressure wound therapy devices, including the PICO wound NPWT wound VAC, wound pump, VAC dressing, portable wound AC, negative pressure pump, Smith Nephew PICO 7, Medela Wound VAC, and the wound VAC, are used to treat chronic wounds as a result of procedures like , VAC dressing pressure, wound VAC therapy, and negative pressure therapy.
RESTRAINT
- It was shown that the cost of NPWT was higher than the cost of traditional therapy. For instance, according to a study by BioMedCentral, the price per person diagnosed with NPWT is $142 higher than the price per particular patient using traditional techniques.
- The care of patients needing such treatments is hampered by the lack of medical practitioners educated in NPWT methods and equipment.
OPPORTUNITIES
- The development of NPWT technology enables patients to heal their wounds more quickly. The equipment itself is expensive to install, but the therapy itself is cheap. This offers the negative pressure wound therapy sector a real possibility for expansion.
- In homecare settings, the adoption of transportable and throwaway NPWT models protects patients from reinfections that can result in potential amputations. Additionally, it avoids the hospital stay expenses and enables the patient to feel comfortable at his own house. A study found that the starting price for NPWT treatment for home care is about USD 90. In order to take advantage of future market prospects, the governmental organizations are stressing the improvement in the manufacture of certain NPWT models.
MARKET SEGMENTATION
BY PRODUCT
With a CAGR of 5.5%, the “Conventional NPWT device” held the greatest market share in 2019. This is linked to lower total treatment costs brought on by shorter stays and improved management of serious wounds. The average duration of treatment for NPWT was 9.7 days as opposed to 11.2 days for traditional treatment.
BY WOUND TYPE
With a CAGR of almost 6%, the Chronic Wounds sector had the greatest market share in 2019. This is due to the anticipated rise in chronic diseases among people, which could result in chronic wounds. 6.5 million Individuals in the US are affected by chronic wounds, according to the NCBI.
BY END-USER
The Hospitals segment, which brought in USD 597.5 million, had the greatest market share. This can be ascribed to an increase in the number of patients seeking treatment for chronic and acute wounds as well as the rate of infection from surgical wounds. According to studies, the general population’s rate of surgical wound infection ranges from 8% to 25% in adults over the age of 60.
BY REGION
North America held the greatest market share, contributing a total of USD 702 million. The market in this area experienced tremendous growth as a result of the introduction of inexpensive NPWT technology, the growing elderly population, and the rise in chronic wound cases. In the United States, there are more than 2.5 million people who have pressure ulcers.
During the predicted period, the Asia-Pacific area had the fastest CAGR. The main factors that are notably driving market expansion are the huge rise in chronic wounds caused by long-term diseases in this location and technological advancements in NPWT devices. It is estimated that China has 1.07 billion diabetics between the ages of 20 and 79.
TOP MARKET PLAYERS
- ConvaTec Inc.
- Smith & Nephew
- Cardinal Health
- Medela AG Mölnlycke Health Care AB
- Medela AG
- Talley Group Ltd.
- PAUL HARTMANN Asia-Pacific Ltd. 3M Acelity L.P. Inc.
- Lohmann and Rauscher GmbH & Co. KG
- PAUL HARTMANN Asia-Pacific Ltd.